HMGB1 and cancer: Consequently, elevated HMGB1 expression contributes to a radio-resistant phenotype, whereas its depletion renders cancer cells vulnerable to DNA-damaging treatments, suggesting that therapeutic targeting of HMGB1 may represent a potential promising frontier for sensitizing tumors to anti-cancer therapy [60].